Driving change in Cell & Gene Therapies: Key learnings from the SITC Virtual Summit
Chris Learn, Head of Cell and Gene COE at Parexel discusses his participation at the recent Clinical Research Virtual Summit hosted by the Society for Immunotherapy of Cancer, and the implications for clinical research.
Related Insights
Podcast
Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
SITC Crisis in Clinical Research Virtual Summit – Collaborating to Drive Change
Aug 24, 2022
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Podcast
De-risking Drug Development | Episode 1: How to drive value in pre-clinical development
May 28, 2024
Webinar
Highlights from ESMO 2024: How does it affect drug development going forward
Oct 11, 2024
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Blog
The New Frontier of Innovative Therapies: Navigating What's Next
Jan 12, 2023
Blog
Innovative modeling method could speed patient access to critical IO therapies
Jan 4, 2023
Article
Five strategies for meeting the requirements of Project Optimus and improving the chances of approval
Nov 10, 2022
Article
Q&A Project Optimus: What you need to know
Oct 11, 2022
Blog
What Do the Next 10 Years Hold for CRISPR?
Jul 27, 2022
Video
Cell & Gene Therapies: A Regulatory Update
Jul 22, 2022
Related Insights
Podcast
Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
SITC Crisis in Clinical Research Virtual Summit – Collaborating to Drive Change
Aug 24, 2022
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Podcast
De-risking Drug Development | Episode 1: How to drive value in pre-clinical development
May 28, 2024
Webinar
Highlights from ESMO 2024: How does it affect drug development going forward
Oct 11, 2024
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Blog
The New Frontier of Innovative Therapies: Navigating What's Next
Jan 12, 2023
Blog
Innovative modeling method could speed patient access to critical IO therapies
Jan 4, 2023
Article
Five strategies for meeting the requirements of Project Optimus and improving the chances of approval
Nov 10, 2022
Article
Q&A Project Optimus: What you need to know
Oct 11, 2022
Blog
What Do the Next 10 Years Hold for CRISPR?
Jul 27, 2022
Video
Cell & Gene Therapies: A Regulatory Update
Jul 22, 2022